If you read this from a Drug Company point of view, ENZC just put out the best most strategic PR I have seen which sets them waaaay apart from other COVID-19 plays. Let me explain and hope people can follow..
ENZC said the following:
As it relates to the CMO and production of the initial validation batch of our lead product ITV-1, which will be marketed in Europe as ImmunH through our partner, Immunotech Laboratories BG-Europe. This is for the treatment of HIV/Aids, and the validation batch production is for the purpose of Phase IV, as required by the regulatory agencies as part of the mass use permitting process.
ENZC, is not they are not saying their drugs dont treat other major viruses. They are open to other deciding authorities using their "main" HIV immune drugs and patents for other uses but they want the final product to be a HIV drug. For example, the drug Metformin is specifically used for those with Diabeties and was created for that purpose alone. ---->>>>It is a Diabeties drug 'FIRST". However it has been proven to have medical properties to help many with heart disease lose weight and Doctors prescribe it to patients for reasons other than Diabeties. ENZC is open for others using their drugs to treat other viruses, but they want it to be know that their drug is a HIV drug first!!!
What they are saying here is more than anything they are a HIV DRUG COMPANY FIRST!!! They are not claiming to be a COVID-19 P&D company that cures this disease like we see in other Pr's.
News 
Market Data 
Discover 
